Cargando…
There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders
BACKGROUND: Soluble CD200 (sCD200) is a novel immuno-effective molecule, which acts to regulate inflammatory and acquired immune responses. Recently, our study group showed that sCD200 was present in serum and blister fluid in a patient with bullous pemphigoid and a patient with toxic epidermal necr...
Autores principales: | Akman-Karakaş, Ayşe, Yalcin, Arzu Didem, Koç, Saliha, Gumuslu, Saadet, Şenol, Yeşim Yiğiter, Özkesici, Birgül, Genc, Gizem Esra, Ergun, Erkan, Ongut, Gozde, Yilmaz, Ertan, Uzun, Soner, Alpsoy, Erkan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809986/ https://www.ncbi.nlm.nih.gov/pubmed/24157657 http://dx.doi.org/10.12659/MSM.889624 |
Ejemplares similares
-
PUVA Induced Bullous Pemphigoid in a Patient with Mycosis Fungoides
por: Özkesici, Birgül, et al.
Publicado: (2017) -
Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: Association with disease activity
por: Arik, Hasan Onur, et al.
Publicado: (2014) -
Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013) -
Successful Treatment of a Bullous Pemphigoid Patient with Rituximab Who Was Refractory to Corticosteroid and Omalizumab Treatments
por: Bilgiç Temel, Aslı, et al.
Publicado: (2017) -
Standard Patch Test Results and Clinical Relevance: A Cross-Sectional Study of 10-year Retrospective Experience
por: Bilgic, Aslı, et al.
Publicado: (2022)